GlassScriptPhysician profile
Ayesha Ahmar
NPI 1215955000
$7,547.88
in general payments reported to CMS, 2019-2025
37 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $504 · 2021: $968 · 2022: $627 · 2023: $1,032 · 2024: $1,732 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,604.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,091.14 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $763.82 | 2021-2025 | |
| Amgen INC. | $756.98 | 2019-2025 | Repatha, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $493.06 | 2019-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $469.40 | 2019-2025 | Rybelsus, Ozempic |
| Medtronic, INC. | $469.14 | 2024-2025 | In.Pact Admiral, Hawkone, Percept PC Brainsense |
| Glaxosmithkline, LLC. | $404.36 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $345.69 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Allergan, INC. | $238.60 | 2020 | |
| Pfizer INC. | $189.37 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $177.18 | 2023 | Rosa |
| Axsome Therapeutics, INC. | $176.44 | 2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $169.22 | 2023 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $167.40 | 2019-2021 | |
| Teleflex LLC | $161.50 | 2025 | Urolift |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayesha Ahmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.